Cigarette Smoking and PM Might Jointly Exacerbate the Risk of Metabolic Syndrome

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Jan 30

PMID 38288423

Authors

Hao-Hung Tsai

Disline Manli Tantoh

Wen Yu Lu

Chih-Yi Chen

Yung-Po Liaw

Affiliations

Soon will be listed here.

Abstract

Background: Cigarette smoking and particulate matter (PM) with aerodynamic diameter < 2.5 μm (PM) are major preventable cardiovascular mortality and morbidity promoters. Their joint role in metabolic syndrome (MS) pathogenesis is unknown. We determined the risk of MS based on PM and cigarette smoking in Taiwanese adults.

Methods: The study included 126,366 Taiwanese between 30 and 70 years old with no personal history of cancer. The Taiwan Biobank (TWB) contained information on MS, cigarette smoking, and covariates, while the Environmental Protection Administration (EPA), Taiwan, contained the PM information. Individuals were categorized as current, former, and nonsmokers. PM levels were categorized into quartiles: PM ≤ Q1, Q1 < PM ≤ Q2, Q2 < PM ≤ Q3, and PM > Q3, corresponding to PM ≤ 27.137, 27.137 < PM ≤ 32.589, 32.589 < PM ≤ 38.205, and PM > 38.205 μg/m.

Results: The prevalence of MS was significantly different according to PM exposure (-value = 0.0280) and cigarette smoking (-value < 0.0001). Higher PM levels were significantly associated with a higher risk of MS: odds ratio (OR); 95% confidence interval (CI) = 1.058; 1.014-1.104, 1.185; 1.134-1.238, and 1.149; 1.101-1.200 for 27.137 < PM ≤ 32.589, 32.589 < PM ≤ 38.205, and PM > 38.205 μg/m, respectively. The risk of MS was significantly higher among former and current smokers with OR; 95% CI = 1.062; 1.008-1.118 and 1.531; 1.450-1.616, respectively, and a dose-dependent -value < 0.0001. The interaction between both exposures regarding MS was significant (-value = 0.0157). Stratification by cigarette smoking revealed a significant risk of MS due to PM exposure among nonsmokers: OR (95% CI) = 1.074 (1.022-1.128), 1.226 (1.166-1.290), and 1.187 (1.129-1.247) for 27.137 < PM ≤ 32.589, 32.589 < PM ≤ 38.205, and PM > 38.205 μg/m, respectively. According to PM quartiles, current smokers had a higher risk of MS, regardless of PM levels (OR); 95% CI = 1.605; 1.444-1.785, 1.561; 1.409-1.728, 1.359; 1.211-1.524, and 1.585; 1.418-1.772 for PM ≤ 27.137, 27.137 < PM ≤ 32.589, 32.589 < PM ≤ 38.205, and PM > 38.205 μg/m, respectively. After combining both exposures, the group, current smokers; PM > 38.205 μg/m had the highest odds (1.801; 95% CI =1.625-1.995).

Conclusion: PM and cigarette smoking were independently and jointly associated with a higher risk of MS. Stratified analyses revealed that cigarette smoking might have a much higher effect on MS than PM. Nonetheless, exposure to both PM and cigarette smoking could compound the risk of MS.

Citing Articles

Metabolic syndrome index measurement tool (MSI): scale development, reliability and validity study.

Akeren Z, Apaydin E BMC Public Health. 2025; 25(1):51.

PMID: 39762795 PMC: 11705882. DOI: 10.1186/s12889-025-21304-7.

References

Slagter S, van Vliet-Ostaptchouk J, Vonk J, Boezen H, Dullaart R, Muller Kobold A . Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med. 2013; 11:195. PMC: 3766075. DOI: 10.1186/1741-7015-11-195. View

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

ONeill S, ODriscoll L . Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2014; 16(1):1-12. DOI: 10.1111/obr.12229. View

Shamy M, Alghamdi M, Khoder M, Mohorjy A, Alkhatim A, Alkhalaf A . Association between Exposure to Ambient Air Particulates and Metabolic Syndrome Components in a Saudi Arabian Population. Int J Environ Res Public Health. 2018; 15(1). PMC: 5800127. DOI: 10.3390/ijerph15010027. View

Moradi M, Mokhtari A, Mohammadi M, Hadei M, Vosoughi M . Estimation of long-term and short-term health effects attributed to PM standard pollutants in the air of Ardabil (using Air Q + model). Environ Sci Pollut Res Int. 2021; 29(15):21508-21516. DOI: 10.1007/s11356-021-17303-x. View

Hou J, Liu X, Tu R, Dong X, Zhai Z, Mao Z . Long-term exposure to ambient air pollution attenuated the association of physical activity with metabolic syndrome in rural Chinese adults: A cross-sectional study. Environ Int. 2020; 136:105459. DOI: 10.1016/j.envint.2020.105459. View

Wada T, Urashima M, Fukumoto T . Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007; 46(14):1079-82. DOI: 10.2169/internalmedicine.46.0026. View

Onat A, Ozhan H, Metin Esen A, Albayrak S, Karabulut A, Can G . Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit. Atherosclerosis. 2006; 193(2):380-8. DOI: 10.1016/j.atherosclerosis.2006.07.002. View

Fiorito G, Vlaanderen J, Polidoro S, Gulliver J, Galassi C, Ranzi A . Oxidative stress and inflammation mediate the effect of air pollution on cardio- and cerebrovascular disease: A prospective study in nonsmokers. Environ Mol Mutagen. 2017; 59(3):234-246. DOI: 10.1002/em.22153. View

10.

Zhang J, Gui Z, Zou Z, Yang B, Ma J, Jing J . Long-term exposure to ambient air pollution and metabolic syndrome in children and adolescents: A national cross-sectional study in China. Environ Int. 2021; 148:106383. DOI: 10.1016/j.envint.2021.106383. View

11.

Wang S, Chen J, Wang Y, Yang Y, Zhang D, Liu C . Cigarette Smoking Is Negatively Associated with the Prevalence of Type 2 Diabetes in Middle-Aged Men with Normal Weight but Positively Associated with Stroke in Men. J Diabetes Res. 2019; 2019:1853018. PMC: 6755302. DOI: 10.1155/2019/1853018. View

12.

Lee J, Yoo J, Park H . Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study. Breast Cancer Res Treat. 2017; 162(2):389-393. DOI: 10.1007/s10549-017-4131-x. View

13.

Frati A, Iniestra F, Ariza C . Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care. 1996; 19(2):112-8. DOI: 10.2337/diacare.19.2.112. View

14.

Sheppard L, Burnett R, Szpiro A, Kim S, Jerrett M, Pope 3rd C . Confounding and exposure measurement error in air pollution epidemiology. Air Qual Atmos Health. 2012; 5(2):203-216. PMC: 3353104. DOI: 10.1007/s11869-011-0140-9. View

15.

Ronnemaa T, Ronnemaa E, Puukka P, Pyorala K, Laakso M . Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care. 1996; 19(11):1229-32. DOI: 10.2337/diacare.19.11.1229. View

16.

Akter S, Goto A, Mizoue T . Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis. J Epidemiol. 2017; 27(12):553-561. PMC: 5623034. DOI: 10.1016/j.je.2016.12.017. View

17.

Wallwork R, Colicino E, Zhong J, Kloog I, Coull B, Vokonas P . Ambient Fine Particulate Matter, Outdoor Temperature, and Risk of Metabolic Syndrome. Am J Epidemiol. 2016; 185(1):30-39. PMC: 5209587. DOI: 10.1093/aje/kww157. View

18.

Puett R, Schwartz J, Hart J, Yanosky J, Speizer F, Suh H . Chronic particulate exposure, mortality, and coronary heart disease in the nurses' health study. Am J Epidemiol. 2008; 168(10):1161-8. PMC: 2732957. DOI: 10.1093/aje/kwn232. View

19.

Battelli M, Bortolotti M, Polito L, Bolognesi A . Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase. Redox Biol. 2018; 21:101070. PMC: 6302121. DOI: 10.1016/j.redox.2018.101070. View

20.

Ezzati M, Lopez A . Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004; 13(4):388-95. PMC: 1747946. DOI: 10.1136/tc.2003.005215. View